For the latest COVID-19 Travel restrictions and recommendations please click here

in association with

Cytel logo


1.30 - 5.00pm

about the workshop

A Seminar on New Approaches to Dose-Finding Using Adaptive Trials

Designers of phase II dose ranging studies are challenged to find the right doses to carry forward to late stage development.
Adaptive dose finding designs enable investigation of more doses without increasing the sample size. Employing adaptive dose-finding approaches can significantly improve the development process while using similar or smaller subjects compared to conventional, fixed trials.
The FDA's recently issued draft guidelines specifically encourage the use adaptive designs especially in the learning stage of clinical development.  The EMA's position is quite similar.
But exactly how would a trial planning team today go about the process of selecting the best adaptation strategy and trial design method for determining the best dose level to use in final stages of development?

Using case studies and Cytel's latest design tools, we examine how adaptive dose-finding is today helping biopharmaceutical companies of all sizes determine the optimal dose for the registration phase.

what's covered?

A review of the factors to take into account in selecting a successful dose finding trial:

  • The importance of considering both frequentist and Bayesian designs when selecting the best design for an adaptive dose finding clinical trial; both methodologies having been successfully deployed in dose finding trials
  • As neither frequentist nor Bayesian approaches dominates the other in practice, an examination of the advantages and disadvantages with both trial types 
  • Using trial simulation to compare and confidently determine the best adaptive dose-finding trial design

Scroll down for the full programme...


an example:

Accomplishing multiple objectives in a single study

Adaptive dose-finding designs can accomplish multiple objectives in a single study.  Alternatives to the traditional paradigm of multiple, individual clinical trials each requiring their own resources and their requisite start-stop gaps between studies.
Now, a single adaptive trial can replace multiple conventional studies and use fewer total subjects in the process. For example, we can construct one study to effectively cover what traditionally development approaches would have required three separate trials:

1.     1/2 Proof-of-Concept Study to demonstrate that the drug works as intended
2.     Phase 2a Dose-Finding Study to estimate the dose-response relationship
3.     Phase 2b Dose-Response Study to choose the dose(s) for phase 3 trials

about the leaders

James Bolognese, Senior Director for Clinical Trial Services, Cytel Inc




Jim Bolognese joined Merck in 1976, first working on late phase clinical statistical projects. There, Jim led clinical pharmacology projects, pre-clinical statistics, and late phase coxib projects, before forming Merck's experimental medicine statistics group.  Following his Merck career, Jim joined Cytel to further develop adaptive trial designs and supporting software.

Jim has actively researched and published on dose-adaptive designs in early phase development.  During his experimental medicine statistics role, he designed and assisted implementation of a single dose-adaptive trial that accomplished both proof-of-concept and dose-ranging objectives.

Jim Bolognese designed and served as blinded statistician on the steering committees of two large outcomes studies.  He has co-authored over 50 publications in the biostatistics and medical research literature. Jim earned a Mathematics BS from Bucknell University and his Masters in Statistics from University of Florida.

Also presenting at the workshop will be:

Roman Torgovitsky, Biostatistician, Cytel Inc

about the organisation

Cytel Inc is a premier provider of clinical trial design services and specialised statistical software for the biopharmaceutical, medical device, academic, and government research markets.  47 of the top 50 biopharmaceutical companies rely on Cytel software to design, simulate and analyse both their adaptive and traditional clinical trials.

Cytel provides study sponsors and international regulators with the innovative tools, training and consultation proven to increase clinical research success rates.

Workshop programme

13:10 Workshop sessions begin

13:30 Registration and coffee

14:00 Welcome and introductions

14:10 Workshop sessions begin

15:30 Coffee break

15:50 Workshop sessions continue

16:30 Q&A and discussion

17:00 End of workshop


Crowne Plaza - The City

19 New Bridge Road
London EC4V 6DB
United Kingdom

Crowne Plaza - The City



speaker image






CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title


Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event


Sign up
Forgotten Password?


UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71

Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out